These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8514652)

  • 21. [Penicillin and ampicillin levels in pathologically altered tissue following regional intravenous administration of antibiotics in cattle legs].
    Stanek C; Fessl L; Awad-Masalmeh M
    Berl Munch Tierarztl Wochenschr; 1984 May; 97(5):162-6. PubMed ID: 6743219
    [No Abstract]   [Full Text] [Related]  

  • 22. [Microbiology and conservative surgery of serious infections of the diabetic foot].
    Díaz Colodrero G; Altclas J; Jasovich A; Mikaelian G; Fiks G; Caro E
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):451-5. PubMed ID: 1489772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clindamycin.
    Klainer AS
    Med Clin North Am; 1987 Nov; 71(6):1169-75. PubMed ID: 3320618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anatomic location of acute diabetic foot infection. Its influence on the outcome of treatment.
    Kaufman J; Breeding L; Rosenberg N
    Am Surg; 1987 Feb; 53(2):109-12. PubMed ID: 3813216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
    Curis E; Pestre V; Jullien V; Eyrolle L; Archambeau D; Morand P; Gatin L; Karoubi M; Pinar N; Dumaine V; Nguyen Van JC; Babinet A; Anract P; Salmon D
    Infection; 2015 Aug; 43(4):473-81. PubMed ID: 25837442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiology of diabetic foot infections.
    Axler DA
    J Foot Surg; 1987; 26(1 Suppl):S3-6. PubMed ID: 3549851
    [No Abstract]   [Full Text] [Related]  

  • 27. Tissue penetration and exposure of cefepime in patients with diabetic foot infections.
    So W; Kuti JL; Shepard A; Nugent J; Nicolau DP
    Int J Antimicrob Agents; 2016 Mar; 47(3):247-8. PubMed ID: 26897754
    [No Abstract]   [Full Text] [Related]  

  • 28. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic ulcers--a clinical and bacteriological study.
    McLigeyo ; Oumah S; Otieno ; Saul L
    West Afr J Med; 1990; 9(2):135-8. PubMed ID: 2268569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A team approach to infections of the lower extremity in the diabetic patient.
    LeFrock JL; Joseph WS
    J Foot Surg; 1987; 26(1 Suppl):S1-2. PubMed ID: 3559049
    [No Abstract]   [Full Text] [Related]  

  • 31. Clindamycin in the treatment of obstetric and gynecologic infections: a review.
    Zambrano D
    Clin Ther; 1991; 13(1):58-80. PubMed ID: 2029726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cortical bone and serum concentrations of clindamycin achievable by direct local infusion and intravenous administration.
    Budsberg SC; Gallo JM; Starliper CE; Shotts EB; Brown J
    J Orthop Res; 1991 Jul; 9(4):594-9. PubMed ID: 2045986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of the formation of suppurative necrotic foot diseases in diabetes (review of the literature)].
    Georgadze AK; Gazetov BM
    Khirurgiia (Mosk); 1985 Aug; (8):141-7. PubMed ID: 3903323
    [No Abstract]   [Full Text] [Related]  

  • 34. Bacteriology of diabetic foot ulcers.
    Sims D; Keating SE; DeVincentis AF
    J Foot Surg; 1984; 23(2):149-51. PubMed ID: 6725864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections.
    Greenberg RN; Cayavec P; Danko LS; Bowen K; Montazemi R; Kearney PA; Johnson SB; Strodel WE
    J Antimicrob Chemother; 1994 Sep; 34(3):391-401. PubMed ID: 7829413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal concentration and excretion of clindamycin by the human stomach.
    Hextall A; Radley S; Andrews JM; Boyd EJ; Dent JC; Donovan I; Wise R
    J Antimicrob Chemother; 1994 Mar; 33(3):595-602. PubMed ID: 8040123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of diabetic patients with serious pedal infections.
    Leichter SB; Allweiss P; Harley J; Clay J; Kuperstein-Chase J; Sweeney GJ; Kolkin J
    Metabolism; 1988 Feb; 37(2 Suppl 1):22-4. PubMed ID: 3340010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Microbiological characteristics of suppurative-necrotic foot diseases in diabetes mellitus].
    Dani'liants EV; Marshava OM; Smakov SB; Macheret EA
    Sov Med; 1989; (11):80-1. PubMed ID: 2516658
    [No Abstract]   [Full Text] [Related]  

  • 39. Clindamycin in dentistry: more than just effective prophylaxis for endocarditis?
    Brook I; Lewis MA; Sándor GK; Jeffcoat M; Samaranayake LP; Vera Rojas J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Nov; 100(5):550-8. PubMed ID: 16243239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of clindamycin and metronidazole into inflamed appendiceal tissue.
    Levy Y; Berger SA; Gorea A; Shnaker A; Orda R
    Eur J Surg; 1996 Aug; 162(8):633-5. PubMed ID: 8891621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.